Shares of Davita Inc (NYSE:DVA) have received an average rating of “Hold” from the fourteen analysts that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, four have assigned a buy rating and two have issued a strong buy rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $79.00.
Several equities research analysts have issued reports on DVA shares. Royal Bank of Canada dropped their target price on Davita from $64.00 to $60.00 and set a “sector perform” rating on the stock in a research report on Wednesday, November 8th. Bank of America dropped their target price on Davita from $75.00 to $66.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 8th. Robert W. Baird restated a “hold” rating and set a $63.00 target price on shares of Davita in a research report on Friday, November 10th. KeyCorp restated a “hold” rating on shares of Davita in a research report on Monday, November 13th. Finally, Raymond James Financial upgraded Davita from an “outperform” rating to a “strong-buy” rating and increased their target price for the stock from $65.00 to $84.00 in a research report on Thursday, December 7th.
Shares of Davita (NYSE DVA) opened at $72.77 on Wednesday. The stock has a market capitalization of $13,340.00, a price-to-earnings ratio of 15.00, a price-to-earnings-growth ratio of 1.59 and a beta of 0.99. Davita has a 12-month low of $52.51 and a 12-month high of $80.71. The company has a current ratio of 2.88, a quick ratio of 2.82 and a debt-to-equity ratio of 1.87.
In related news, VP Leanne M. Zumwalt sold 949 shares of the stock in a transaction on Friday, December 8th. The stock was sold at an average price of $68.19, for a total value of $64,712.31. Following the sale, the vice president now owns 12,423 shares in the company, valued at $847,124.37. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Kent J. Thiry sold 81,800 shares of the stock in a transaction on Friday, December 8th. The stock was sold at an average price of $68.04, for a total value of $5,565,672.00. The disclosure for this sale can be found here. Insiders sold 121,509 shares of company stock worth $8,310,388 in the last quarter. 2.00% of the stock is currently owned by company insiders.
Hedge funds have recently modified their holdings of the stock. Rhumbline Advisers raised its position in shares of Davita by 4.4% in the third quarter. Rhumbline Advisers now owns 321,155 shares of the company’s stock worth $19,073,000 after buying an additional 13,471 shares in the last quarter. Founders Capital Management LLC raised its position in shares of Davita by 2.3% in the third quarter. Founders Capital Management LLC now owns 95,939 shares of the company’s stock worth $5,698,000 after buying an additional 2,115 shares in the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH raised its position in shares of Davita by 1,987.3% in the third quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 41,746 shares of the company’s stock worth $2,448,000 after buying an additional 39,746 shares in the last quarter. Speece Thorson Capital Group Inc. increased its stake in Davita by 14.5% in the third quarter. Speece Thorson Capital Group Inc. now owns 321,182 shares of the company’s stock valued at $19,075,000 after acquiring an additional 40,667 shares during the last quarter. Finally, Eqis Capital Management Inc. increased its stake in Davita by 62.5% in the third quarter. Eqis Capital Management Inc. now owns 7,473 shares of the company’s stock valued at $444,000 after acquiring an additional 2,873 shares during the last quarter. Institutional investors own 82.88% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://www.chaffeybreeze.com/2018/02/21/davita-inc-dva-receives-consensus-recommendation-of-hold-from-analysts.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.